Isoniazid-induced alopecia in isoniazid-monoresistant pulmonary tuberculosis

Key Points

• Alopecia is a notable adverse effect linked to isoniazid treatment for tuberculosis, complicating patient care.
• In a cohort of individuals with isoniazid-monoresistant tuberculosis, 30% experienced alopecia during treatment.
• Observational analysis highlighting the side effects of isoniazid therapy in patients with pulmonary tuberculosis.
• Findings may enable healthcare providers to adjust treatment plans to mitigate hair loss in affected individuals.